188 related articles for article (PubMed ID: 27489283)
1. Rpl22 Loss Selectively Impairs αβ T Cell Development by Dysregulating Endoplasmic Reticulum Stress Signaling.
Solanki NR; Stadanlick JE; Zhang Y; Duc AC; Lee SY; Lauritsen JP; Zhang Z; Wiest DL
J Immunol; 2016 Sep; 197(6):2280-9. PubMed ID: 27489283
[TBL] [Abstract][Full Text] [Related]
2. Ablation of ribosomal protein L22 selectively impairs alphabeta T cell development by activation of a p53-dependent checkpoint.
Anderson SJ; Lauritsen JP; Hartman MG; Foushee AM; Lefebvre JM; Shinton SA; Gerhardt B; Hardy RR; Oravecz T; Wiest DL
Immunity; 2007 Jun; 26(6):759-72. PubMed ID: 17555992
[TBL] [Abstract][Full Text] [Related]
3. Developmental arrest of T cells in Rpl22-deficient mice is dependent upon multiple p53 effectors.
Stadanlick JE; Zhang Z; Lee SY; Hemann M; Biery M; Carleton MO; Zambetti GP; Anderson SJ; Oravecz T; Wiest DL
J Immunol; 2011 Jul; 187(2):664-75. PubMed ID: 21690328
[TBL] [Abstract][Full Text] [Related]
4. Rpl22 Loss Impairs the Development of B Lymphocytes by Activating a p53-Dependent Checkpoint.
Fahl SP; Harris B; Coffey F; Wiest DL
J Immunol; 2015 Jan; 194(1):200-9. PubMed ID: 25416806
[TBL] [Abstract][Full Text] [Related]
5. Loss of Ribosomal Protein Paralog Rpl22-like1 Blocks Lymphoid Development without Affecting Protein Synthesis.
Fahl SP; Sertori R; Zhang Y; Contreras AV; Harris B; Wang M; Perrigoue J; Balachandran S; Kennedy BK; Wiest DL
J Immunol; 2022 Feb; 208(4):870-880. PubMed ID: 35046107
[TBL] [Abstract][Full Text] [Related]
6. Ribosomal Protein Rpl22 Controls the Dissemination of T-cell Lymphoma.
Rao S; Cai KQ; Stadanlick JE; Greenberg-Kushnir N; Solanki-Patel N; Lee SY; Fahl SP; Testa JR; Wiest DL
Cancer Res; 2016 Jun; 76(11):3387-96. PubMed ID: 27197189
[TBL] [Abstract][Full Text] [Related]
7. Lymphotoxin-mediated regulation of gammadelta cell differentiation by alphabeta T cell progenitors.
Silva-Santos B; Pennington DJ; Hayday AC
Science; 2005 Feb; 307(5711):925-8. PubMed ID: 15591166
[TBL] [Abstract][Full Text] [Related]
8. Ribosomal proteins and the control of alphabeta T lineage development.
Murre C
Immunity; 2007 Jun; 26(6):751-2. PubMed ID: 17582347
[TBL] [Abstract][Full Text] [Related]
9. Ribosomal protein RPL22/eL22 regulates the cell cycle by acting as an inhibitor of the CDK4-cyclin D complex.
Del Toro N; Fernandez-Ruiz A; Mignacca L; Kalegari P; Rowell MC; Igelmann S; Saint-Germain E; Benfdil M; Lopes-Paciencia S; Brakier-Gingras L; Bourdeau V; Ferbeyre G; Lessard F
Cell Cycle; 2019; 18(6-7):759-770. PubMed ID: 30874462
[TBL] [Abstract][Full Text] [Related]
10. DL4-mediated Notch signaling is required for the development of fetal αβ and γδ T cells.
Ferrero I; Koch U; Claudinot S; Favre S; Radtke F; Luther SA; MacDonald HR
Eur J Immunol; 2013 Nov; 43(11):2845-53. PubMed ID: 23881845
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Notch1 function by in vitro T cell differentiation of Pax5 mutant lymphoid progenitors.
Höflinger S; Kesavan K; Fuxa M; Hutter C; Heavey B; Radtke F; Busslinger M
J Immunol; 2004 Sep; 173(6):3935-44. PubMed ID: 15356142
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B.
Rao S; Lee SY; Gutierrez A; Perrigoue J; Thapa RJ; Tu Z; Jeffers JR; Rhodes M; Anderson S; Oravecz T; Hunger SP; Timakhov RA; Zhang R; Balachandran S; Zambetti GP; Testa JR; Look AT; Wiest DL
Blood; 2012 Nov; 120(18):3764-73. PubMed ID: 22976955
[TBL] [Abstract][Full Text] [Related]
13. Control of hematopoietic stem cell emergence by antagonistic functions of ribosomal protein paralogs.
Zhang Y; Duc AC; Rao S; Sun XL; Bilbee AN; Rhodes M; Li Q; Kappes DJ; Rhodes J; Wiest DL
Dev Cell; 2013 Feb; 24(4):411-25. PubMed ID: 23449473
[TBL] [Abstract][Full Text] [Related]
14. Cancer-mutated ribosome protein L22 (RPL22/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit.
Cao B; Fang Z; Liao P; Zhou X; Xiong J; Zeng S; Lu H
Oncotarget; 2017 Oct; 8(53):90651-90661. PubMed ID: 29207594
[TBL] [Abstract][Full Text] [Related]
15. Regulatory Roles of Rpl22 in Hematopoiesis: An Old Dog with New Tricks.
Fahl SP; Wang M; Zhang Y; Duc AC; Wiest DL
Crit Rev Immunol; 2015; 35(5):379-400. PubMed ID: 26853850
[TBL] [Abstract][Full Text] [Related]
16. Metabolic signaling directs the reciprocal lineage decisions of αβ and γδ T cells.
Yang K; Blanco DB; Chen X; Dash P; Neale G; Rosencrance C; Easton J; Chen W; Cheng C; Dhungana Y; Kc A; Awad W; Guo XJ; Thomas PG; Chi H
Sci Immunol; 2018 Jul; 3(25):. PubMed ID: 29980617
[TBL] [Abstract][Full Text] [Related]
17. Distinct effects of Jak3 signaling on alphabeta and gammadelta thymocyte development.
Eynon EE; Livák F; Kuida K; Schatz DG; Flavell RA
J Immunol; 1999 Feb; 162(3):1448-59. PubMed ID: 9973401
[TBL] [Abstract][Full Text] [Related]
18. ISWI ATPase Smarca5 Regulates Differentiation of Thymocytes Undergoing β-Selection.
Zikmund T; Kokavec J; Turkova T; Savvulidi F; Paszekova H; Vodenkova S; Sedlacek R; Skoultchi AI; Stopka T
J Immunol; 2019 Jun; 202(12):3434-3446. PubMed ID: 31068388
[TBL] [Abstract][Full Text] [Related]
19. Integrated morphogen signal inputs in gammadelta versus alphabeta T-cell differentiation.
Melichar H; Kang J
Immunol Rev; 2007 Feb; 215():32-45. PubMed ID: 17291277
[TBL] [Abstract][Full Text] [Related]
20. Recent insights into the signals that control alphabeta/gammadelta-lineage fate.
Lauritsen JP; Haks MC; Lefebvre JM; Kappes DJ; Wiest DL
Immunol Rev; 2006 Feb; 209():176-90. PubMed ID: 16448543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
